Global Computational Immunology Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Table of Contents

1 Computational Immunology Market Overview

• 1.1 Product Overview and Scope of Computational Immunology
• 1.2 Classification of Computational Immunology by Type
  • 1.2.1 Global Computational Immunology Revenue by Type: 2015 VS 2019 VS 2025
  • 1.2.2 Global Computational Immunology Revenue Market Share by Type in 2019
  • 1.2.3 Cancer Diagnosis & Therapy
  • 1.2.4 Reverse Vaccinology
  • 1.2.5 Immune System Modeling
• 1.3 Global Computational Immunology Market by Application
  • 1.3.1 Overview: Global Computational Immunology Revenue by Application: 2015 VS 2019 VS 2025
  • 1.3.2 Allergy Prediction Databases
  • 1.3.3 Analysis Resource Database
  • 1.3.4 International Immunogenetics System
  • 1.3.5 The Ontology Of Immune Epitopes
  • 1.3.6 Immune Epitope Database
• 1.4 Global Computational Immunology Market by Regions
  • 1.4.1 Global Computational Immunology Market Size by Regions: 2015 VS 2019 VS 2025
  • 1.4.2 Global Market Size of Computational Immunology (2015-2025)
  • 1.4.3 North America (USA, Canada and Mexico) Computational Immunology Status and Prospect (2015-2025)
  • 1.4.4 Europe (Germany, France, UK, Russia and Italy) Computational Immunology Status and Prospect (2015-2025)
  • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Computational Immunology Status and Prospect (2015-2025)
  • 1.4.6 South America (Brazil, Argentina, Colombia) Computational Immunology Status and Prospect (2015-2025)
  • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Computational Immunology Status and Prospect (2015-2025)

2 Company Profiles

• 2.1 EpiVax
  • 2.1.1 EpiVax Details
  • 2.1.2 EpiVax Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.1.3 EpiVax SWOT Analysis
  • 2.1.4 EpiVax Product and Services
  • 2.1.5 EpiVax Computational Immunology Revenue, Gross Margin and Market Share (2018-2019)
• 2.2 Chemical Computing Group
  • 2.2.1 Chemical Computing Group Details
  • 2.2.2 Chemical Computing Group Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.2.3 Chemical Computing Group SWOT Analysis
  • 2.2.4 Chemical Computing Group Product and Services
  • 2.2.5 Chemical Computing Group Computational Immunology Revenue, Gross Margin and Market Share (2018-2019)
• 2.3 International Society of Vaccines
  • 2.3.1 International Society of Vaccines Details
  • 2.3.2 International Society of Vaccines Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.3.3 International Society of Vaccines SWOT Analysis
  • 2.3.4 International Society of Vaccines Product and Services
  • 2.3.5 International Society of Vaccines Computational Immunology Revenue, Gross Margin and Market Share (2018-2019)
• 2.4 Novozymes Biopharma
  • 2.4.1 Novozymes Biopharma Details
  • 2.4.2 Novozymes Biopharma Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.4.3 Novozymes Biopharma SWOT Analysis
  • 2.4.4 Novozymes Biopharma Product and Services
  • 2.4.5 Novozymes Biopharma Computational Immunology Revenue, Gross Margin and Market Share (2018-2019)
• 2.5 Certara
  • 2.5.1 Certara Details
  • 2.5.2 Certara Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.5.3 Certara SWOT Analysis
  • 2.5.4 Certara Product and Services
  • 2.5.5 Certara Computational Immunology Revenue, Gross Margin and Market Share (2018-2019)
• 2.6 ioGenetics
  • 2.6.1 ioGenetics Details
  • 2.6.2 ioGenetics Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.6.3 ioGenetics SWOT Analysis
  • 2.6.4 ioGenetics Product and Services
  • 2.6.5 ioGenetics Computational Immunology Revenue, Gross Margin and Market Share (2018-2019)
• 2.7 Genedata AG
  • 2.7.1 Genedata AG Details
  • 2.7.2 Genedata AG Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.7.3 Genedata AG SWOT Analysis
  • 2.7.4 Genedata AG Product and Services
  • 2.7.5 Genedata AG Computational Immunology Revenue, Gross Margin and Market Share (2018-2019)
• 2.8 Dassault Systemes
  • 2.8.1 Dassault Systemes Details
  • 2.8.2 Dassault Systemes Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.8.3 Dassault Systemes SWOT Analysis
  • 2.8.4 Dassault Systemes Product and Services
  • 2.8.5 Dassault Systemes Computational Immunology Revenue, Gross Margin and Market Share (2018-2019)
• 2.9 IMGT
  • 2.9.1 IMGT Details
  • 2.9.2 IMGT Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.9.3 IMGT SWOT Analysis
  • 2.9.4 IMGT Product and Services
  • 2.9.5 IMGT Computational Immunology Revenue, Gross Margin and Market Share (2018-2019)
• 2.10 Compugen
  • 2.10.1 Compugen Details
  • 2.10.2 Compugen Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.10.3 Compugen SWOT Analysis
  • 2.10.4 Compugen Product and Services
  • 2.10.5 Compugen Computational Immunology Revenue, Gross Margin and Market Share (2018-2019)
• 2.11 Schrodinger
  • 2.11.1 Schrodinger Details
  • 2.11.2 Schrodinger Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.11.3 Schrodinger SWOT Analysis
  • 2.11.4 Schrodinger Product and Services
  • 2.11.5 Schrodinger Computational Immunology Revenue, Gross Margin and Market Share (2018-2019)
• 2.12 Insilico Biotechnology AG
  • 2.12.1 Insilico Biotechnology AG Details
  • 2.12.2 Insilico Biotechnology AG Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.12.3 Insilico Biotechnology AG SWOT Analysis
  • 2.12.4 Insilico Biotechnology AG Product and Services
  • 2.12.5 Insilico Biotechnology AG Computational Immunology Revenue, Gross Margin and Market Share (2018-2019)
• 2.13 Simulation Plus
  • 2.13.1 Simulation Plus Details
  • 2.13.2 Simulation Plus Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.13.3 Simulation Plus SWOT Analysis
  • 2.13.4 Simulation Plus Product and Services
  • 2.13.5 Simulation Plus Computational Immunology Revenue, Gross Margin and Market Share (2018-2019)
• 2.14 Strand Life Sciences
  • 2.14.1 Strand Life Sciences Details
  • 2.14.2 Strand Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.14.3 Strand Life Sciences SWOT Analysis
  • 2.14.4 Strand Life Sciences Product and Services
  • 2.14.5 Strand Life Sciences Computational Immunology Revenue, Gross Margin and Market Share (2018-2019)
• 2.15 Leadscope Inc
  • 2.15.1 Leadscope Inc Details
  • 2.15.2 Leadscope Inc Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.15.3 Leadscope Inc SWOT Analysis
  • 2.15.4 Leadscope Inc Product and Services
  • 2.15.5 Leadscope Inc Computational Immunology Revenue, Gross Margin and Market Share (2018-2019)
• 2.16 Rosa & Co
  • 2.16.1 Rosa & Co Details
  • 2.16.2 Rosa & Co Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.16.3 Rosa & Co SWOT Analysis
  • 2.16.4 Rosa & Co Product and Services
  • 2.16.5 Rosa & Co Computational Immunology Revenue, Gross Margin and Market Share (2018-2019)
• 2.17 Nimbus Discovery
  • 2.17.1 Nimbus Discovery Details
  • 2.17.2 Nimbus Discovery Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.17.3 Nimbus Discovery SWOT Analysis
  • 2.17.4 Nimbus Discovery Product and Services
  • 2.17.5 Nimbus Discovery Computational Immunology Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

• 3.1 Global Computational Immunology Revenue and Share by Players (2015-2020)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Computational Immunology Players Market Share
  • 3.2.2 Top 10 Computational Immunology Players Market Share
• 3.3 Market Competition Trend

4 Market Size by Regions

• 4.1 Global Computational Immunology Revenue and Market Share by Regions
• 4.2 North America Computational Immunology Revenue and Growth Rate (2015-2020)
• 4.3 Europe Computational Immunology Revenue and Growth Rate (2015-2020)
• 4.4 Asia-Pacific Computational Immunology Revenue and Growth Rate (2015-2020)
• 4.5 South America Computational Immunology Revenue and Growth Rate (2015-2020)
• 4.6 Middle East & Africa Computational Immunology Revenue and Growth Rate (2015-2020)

5 North America Computational Immunology Revenue by Countries

• 5.1 North America Computational Immunology Revenue by Countries (2015-2020)
• 5.2 USA Computational Immunology Revenue and Growth Rate (2015-2020)
• 5.3 Canada Computational Immunology Revenue and Growth Rate (2015-2020)
• 5.4 Mexico Computational Immunology Revenue and Growth Rate (2015-2020)

6 Europe Computational Immunology Revenue by Countries

• 6.1 Europe Computational Immunology Revenue by Countries (2015-2020)
• 6.2 Germany Computational Immunology Revenue and Growth Rate (2015-2020)
• 6.3 UK Computational Immunology Revenue and Growth Rate (2015-2020)
• 6.4 France Computational Immunology Revenue and Growth Rate (2015-2020)
• 6.5 Russia Computational Immunology Revenue and Growth Rate (2015-2020)
• 6.6 Italy Computational Immunology Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Computational Immunology Revenue by Countries

• 7.1 Asia-Pacific Computational Immunology Revenue by Countries (2015-2020)
• 7.2 China Computational Immunology Revenue and Growth Rate (2015-2020)
• 7.3 Japan Computational Immunology Revenue and Growth Rate (2015-2020)
• 7.4 Korea Computational Immunology Revenue and Growth Rate (2015-2020)
• 7.5 India Computational Immunology Revenue and Growth Rate (2015-2020)
• 7.6 Southeast Asia Computational Immunology Revenue and Growth Rate (2015-2020)

8 South America Computational Immunology Revenue by Countries

• 8.1 South America Computational Immunology Revenue by Countries (2015-2020)
• 8.2 Brazil Computational Immunology Revenue and Growth Rate (2015-2020)
• 8.3 Argentina Computational Immunology Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Computational Immunology by Countries

• 9.1 Middle East & Africa Computational Immunology Revenue by Countries (2015-2020)
• 9.2 Saudi Arabia Computational Immunology Revenue and Growth Rate (2015-2020)
• 9.3 UAE Computational Immunology Revenue and Growth Rate (2015-2020)
• 9.4 Egypt Computational Immunology Revenue and Growth Rate (2015-2020)
• 9.5 South Africa Computational Immunology Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

• 10.1 Global Computational Immunology Revenue and Market Share by Type (2015-2020)
• 10.2 Global Computational Immunology Market Forecast by Type (2019-2024)
• 10.3 Cancer Diagnosis & Therapy Revenue Growth Rate (2015-2025)
• 10.4 Reverse Vaccinology Revenue Growth Rate (2015-2025)
• 10.5 Immune System Modeling Revenue Growth Rate (2015-2025)

11 Global Computational Immunology Market Segment by Application

• 11.1 Global Computational Immunology Revenue Market Share by Application (2015-2020)
• 11.2 Computational Immunology Market Forecast by Application (2019-2024)
• 11.3 Allergy Prediction Databases Revenue Growth (2015-2020)
• 11.4 Analysis Resource Database Revenue Growth (2015-2020)
• 11.5 International Immunogenetics System Revenue Growth (2015-2020)
• 11.6 The Ontology Of Immune Epitopes Revenue Growth (2015-2020)
• 11.7 Immune Epitope Database Revenue Growth (2015-2020)

12 Global Computational Immunology Market Size Forecast (2021-2025)

• 12.1 Global Computational Immunology Market Size Forecast (2021-2025)
• 12.2 Global Computational Immunology Market Forecast by Regions (2021-2025)
• 12.3 North America Computational Immunology Revenue Market Forecast (2021-2025)
• 12.4 Europe Computational Immunology Revenue Market Forecast (2021-2025)
• 12.5 Asia-Pacific Computational Immunology Revenue Market Forecast (2021-2025)
• 12.6 South America Computational Immunology Revenue Market Forecast (2021-2025)
• 12.7 Middle East & Africa Computational Immunology Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Data Source
• 14.3 Disclaimer